JP Patent

JP4245682B2 — キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤

Assigned to Kyowa Kirin Co Ltd · Expires 2009-03-25 · 17y expired

What this patent protects

Patent listed against Zavzpret.

Drugs covered by this patent

Zavzpret (Zavegepant Hydrochloride) · Pfizer

Patent Metadata

Patent number: JP4245682B2
Jurisdiction: JP
Classification: —
Expires: 2009-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Kyowa Kirin Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.